| |
| |
|
| Insider
Information: |
Mclaughlin John Peter |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
553,738 |
|
|
Indirect Shares
|
41,184 |
|
|
| Direct
Value |
$9,836,075 |
|
|
|
Indirect Value
|
$243,555 |
|
|
| Total
Shares |
594,922 |
|
|
| Total
Value |
$10,079,631 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -10.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anesiva Inc |
ANSVQ |
Chief Executive Office... |
2007-03-29 |
113,400 |
2007-03-29 |
14,624 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2020-12-22 |
200,000 |
2009-01-02 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
Director |
2016-05-20 |
39,400 |
2011-09-09 |
0 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
Director |
2016-02-12 |
10,333 |
2016-02-12 |
26,560 |
Premium* |
|
|
Rockwell Medical Technologies Inc |
RMTI |
Director |
2021-06-17 |
136,974 |
2019-09-05 |
0 |
Premium* |
|
|
Lensar, Inc. |
LNSR |
Director |
2023-05-25 |
53,631 |
2022-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
10,333 |
0 |
- |
|
| ANSVQ |
Anesiva Inc |
President and CEOOfficer |
• • – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,500 |
|
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2014-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
26,560 |
13,280 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
Director |
– • – |
2019-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
22,559 |
22,559 |
0 |
- |
|
| ANSVQ |
Anesiva Inc |
President & CEO |
• • – |
2005-03-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
25,000 |
|
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2011-09-09 |
4 |
OE |
$9.82 |
$245,500 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
28,500 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
32,000 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
Director |
– • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
12,615 |
35,174 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
35,700 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
39,400 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2022-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,285 |
44,343 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President & CEO |
• • – |
2009-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
47,916 |
47,916 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,288 |
53,631 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President and CEO |
• • – |
2009-09-15 |
4 |
OE |
$5.41 |
$153,839 |
D/D |
28,415 |
76,331 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
Director |
– • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
51,800 |
86,974 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President and CEO |
• • – |
2011-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
30,501 |
106,832 |
0 |
- |
|
| ANSVQ |
Anesiva Inc |
Chief Executive Officer |
• • – |
2007-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
113,400 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
136,974 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President/Chief Exec. Officer |
• – – |
2012-01-18 |
4 |
A |
$6.29 |
$200,997 |
D/D |
31,955 |
138,787 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President, CEO |
• • – |
2013-01-24 |
4 |
A |
$6.72 |
$201,002 |
D/D |
29,911 |
168,698 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2020-12-22 |
4 |
S |
$2.61 |
$724,574 |
D/D |
(277,934) |
200,000 |
0 |
% |
|
| ANSVQ |
Anesiva Inc |
President & CEO |
• • – |
2005-03-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
249,603 |
|
- |
|
| ANSVQ |
Anesiva Inc |
President and CEOOfficer |
• • – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
287,500 |
|
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
